Novartis to cut 220 jobs and close German production site
Swiss drugmaker Novartis will cut 220 jobs in Germany as it closes its Wehr production site by 2028. The facility is no longer considered competitive.
Xurve View
Insights:
Xurve View
NOVARTIS AG-REG will cut 220 jobs in Germany as it closes its Wehr production facility by the end of 2028. The Switzerland-based drugmaker cited a lack of competitiveness at the site, which manufactures tablets and capsules. The closure reflects ongoing efforts to optimize manufacturing footprints as pharmaceutical giants face increasing pressure on production costs.
